Skip to content
Saturday, August 16, 2025
  • Home
  • BCS News
    • Latest from BCS
    • BCS Editorials
    • Obituaries
    • Editors
  • COVID-19
  • BCS Home

Tag: transthyretin cardiac amyloidosis

Heart Failure Latest News Other Categories

New 2021 ESC Guidelines for the diagnosis and management of heart failure published

CardioNewsUK 31 August 2021 EHJESCESC Congress 2021Heart Failurereduced ejection fractiontransthyretin cardiac amyloidosis

By Ahmed El-Medany The 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) were published on the 27th of…

View More New 2021 ESC Guidelines for the diagnosis and management of heart failure published

Video

https://youtu.be/jpDhCKcM7ak

RSS Heart Journal

  • Terminal renal failure as a contributor to high-sensitivity cardiac troponin T elevations: insights from patients undergoing renal transplantation
  • Perceived health, psychological distress and quality of life in 8415 adults with congenital heart disease from 32 countries
  • Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study
  • Inflammation in coronary atherosclerosis: diagnosis and treatment
  • Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction

RSS AHA Journal Feed

  • Cardiovascular Health Effects and Synthetic Cooling Agents in E‐Cigarettes Labeled as “Clear” Marketed in Massachusetts After the Tobacco Product Flavoring Ban
  • Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study
  • Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease
  • Cognitive Assessments in Randomized Controlled Trials of Acute or Secondary Prevention Stroke Treatments 2011 to 2024: A Scoping Review
  • Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction
UK Cardiology News |
British Cardiovascular Society
✕
BCS Heartbeat

FREE
VIEW